Moderna stock dropped 18% after the company slashed its 2025 revenue forecast by $1 billion, citing declining COVID vaccine demand, market competition, and other financial...
Markets opened higher Monday as investors awaited the Federal Reserve’s meeting, with key rate decisions and 2025 projections expected, while Nasdaq reshuffle pressured Super Micro...